GigaMune
San Francisco
About GigaMune
GigaMune was founded as a spin-out from GigaGen in 2017. They are combining unique insight into T cell responses to tumors with massively parallel T cell receptor (TCR) discovery to develop the next generation of T cell therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $300.0K
- Funding stage: Seed
- Last round: Seed (Mar 2023)
- Website: gigamune.com
Industries & Categories
Biotechnology, Manufacturing, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gigamune-142862 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.